Li, Pp. Could we use clinical benefit to evaluate the effects of chinese medicine on the treatment of cancer?., Chin. J. Integr. Med. 16, 9–10 (2010). https://doi.org/10.1007/s11655-010-0009-z
Ping-ping Li. Could we use clinical benefit to evaluate the effects of chinese medicine on the treatment of cancer?[J]. Chinese Journal of Integrative Medicine, 2010,16(1):9-10.
Li, Pp. Could we use clinical benefit to evaluate the effects of chinese medicine on the treatment of cancer?., Chin. J. Integr. Med. 16, 9–10 (2010). https://doi.org/10.1007/s11655-010-0009-zDOI:
Ping-ping Li. Could we use clinical benefit to evaluate the effects of chinese medicine on the treatment of cancer?[J]. Chinese Journal of Integrative Medicine, 2010,16(1):9-10. DOI: 10.1007/s11655-010-0009-z.
Could we use clinical benefit to evaluate the effects of chinese medicine on the treatment of cancer?
摘要
Abstract
关键词
Overall SurvivalgemcitabineAdvanced Breast CancerAnastrozoleWestern Medicine
Keywords
Overall SurvivalgemcitabineAdvanced Breast CancerAnastrozoleWestern Medicine
references
Burriss HA 3rd, Moore MJ, Andersec J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitaine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403–2413.